Hedge Funds Are Selling BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders have witnessed a decrease in hedge fund interest lately. This is interesting, because the stock is up big today, after continuing bullishness over its peramivir/FDA letter earlier in the week. So why would hedge funds sell?

To the average investor, there are a multitude of gauges market participants can use to track the equity markets. Some of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best hedge fund managers can outclass the S&P 500 by a very impressive margin (see just how much).

Equally as integral, optimistic insider trading sentiment is another way to parse down the stock market universe. There are lots of incentives for a corporate insider to drop shares of his or her company, but only one, very simple reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the useful potential of this tactic if investors understand where to look (learn more here).

Now, it’s important to take a peek at the recent action encompassing BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX).

Hedge fund activity in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

In preparation for this year, a total of 4 of the hedge funds we track were bullish in this stock, a change of -43% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were upping their stakes meaningfully.

Richard Driehaus

Due to the fact that BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has faced bearish sentiment from hedge fund managers, logic holds that there was a specific group of funds who were dropping their full holdings heading into 2013. At the top of the heap, Richard Driehaus’s Driehaus Capital sold off the biggest stake of all the hedgies we track, comprising close to $3 million in stock., and Jim Simons of Renaissance Technologies was right behind this move, as the fund dropped about less than $1 million worth. These moves are important to note, as aggregate hedge fund interest was cut by 3 funds heading into 2013.

What have insiders been doing with BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)?

Insider purchases made by high-level executives is at its handiest when the company in question has seen transactions within the past 180 days. Over the latest six-month time period, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has experienced 2 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). These stocks are StemCells Inc (NASDAQ:STEM), EntreMed Inc (NASDAQ:ENMD), Lpath, Inc. (NASDAQ:LPTN), Transition Therapeutics Inc (USA) (NASDAQ:TTHI), and Savient Pharmaceuticals, Inc. (NASDAQ:SVNT). This group of stocks are the members of the biotechnology industry and their market caps are similar to BCRX’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
StemCells Inc (NASDAQ:STEM) 3 0 0
EntreMed Inc (NASDAQ:ENMD) 0 0
Lpath, Inc. (NASDAQ:LPTN) 2 2 0
Transition Therapeutics Inc (USA) (NASDAQ:TTHI) 2 0 0
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) 5 0 5

With the returns shown by Insider Monkey’s research, retail investors should always keep an eye on hedge fund and insider trading sentiment, and BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) applies perfectly to this mantra.

Click here to learn why you should track hedge funds

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!